Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up

被引:21
作者
Chamalidou, C. [1 ,2 ]
Fohlin, H. [3 ,4 ]
Albertsson, P. [1 ,5 ]
Arnesson, L. -G. [4 ]
Einbeigi, Z. [1 ,6 ]
Holmberg, E. [1 ,7 ]
Nordenskjold, A. [6 ]
Nordenskjold, B. [3 ]
Karlsson, P. [1 ,5 ]
Linderholm, B. [1 ,5 ]
机构
[1] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden
[2] Skaraborg Hosp, Dept Oncol, Skovde, Sweden
[3] Linkoping Univ Hosp, Reg Canc Ctr Southeast Sweden, Linkoping, Sweden
[4] Linkoping Univ, Fac Med, Dept Biomed & Clin Sci, Linkoping, Sweden
[5] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden
[6] Sodra Alvsborgs Hosp, Dept Oncol, Boras, Sweden
[7] Sahlgrens Univ Hosp, Reg Canc Ctr Western Sweden, Gothenburg, Sweden
关键词
Relative survival rate; Excess mortality rate ratio; Lobular breast cancer; Ductal breast cancer; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC VALUE; LONG-TERM; CARCINOMA; FEATURES; RECURRENCE; EXPRESSION; METASTASES; TAMOXIFEN;
D O I
10.1016/j.breast.2021.07.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Invasive lobular carcinoma (ILC) comprises 8-15 % of all invasive breast cancers and large population-based studies with >10 years of follow-up are rare. Whether ILC has a long-time prognosis different from that of invasive ductal carcinoma, (IDC) remains controversial. Purpose: To investigate the excess mortality rate ratio (EMRR) of patients with ILC and IDC and to correlate survival with clinical parameters in a large population-based cohort. Material and methods: From 1989 through 2006, we identified 17,481 patients diagnosed with IDC (n = 14,583) or ILC (n = 2898), younger than 76 years from two Swedish Regional Cancer Registries. Relative survival (RS) during 20 years of follow up was analysed. Results: ILC was significantly associated with older age, larger tumours, ER positivity and well differentiated tumours. We noticed an improved survival for patients with ILC during the first five years, excess mortality rate ratio (EMRR) 0.64 (CI 95 % 0.53-0.77). This was shifted to a significant decreased survival 10-15 years after diagnosis (EMRR 1.49, CI 95 % 1.16-1.93). After 20 years the relative survival rates were similar, 0.72 for ILC and 0.73 for IDC. Conclusions: During the first five years after surgery, the EMRR was lower for patients with ILC as compared to patients with IDC, but during the years 10-15 after surgery, we observed an increased EMRR for patients with ILC as compared to IDC. These EMRR between ILC and IDC were statistically significant but the absolute difference in excess mortality between the two groups was small. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:294 / 300
页数:7
相关论文
共 37 条
[1]   Prognostic value of morphology and hormone receptor status in breast cancer -: a population-based study [J].
Allemani, C ;
Sant, M ;
Berrino, F ;
Aareleid, T ;
Chaplain, G ;
Coebergh, JW ;
Colonna, M ;
Contiero, P ;
Danzon, A ;
Federico, M ;
Gafà, L ;
Grosclaude, P ;
Hédelin, G ;
Macè-Lesech, J ;
Garcia, CM ;
Paci, E ;
Raverdy, N ;
Tretarre, B ;
Williams, EMI .
BRITISH JOURNAL OF CANCER, 2004, 91 (07) :1263-1268
[2]   Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer [J].
Andre, Fabrice ;
Ciruelos, Eva ;
Rubovszky, Gabor ;
Campone, Mario ;
Loibl, Sibylle ;
Rugo, Hope S. ;
Iwata, Hiroji ;
Conte, Pierfranco ;
Mayer, Ingrid A. ;
Kaufman, Bella ;
Yamashita, Toshinari ;
Lu, Yen-Shen ;
Inoue, Kenichi ;
Takahashi, Masato ;
Papai, Zsuzsanna ;
Longin, Anne-Sophie ;
Mills, David ;
Wilke, Celine ;
Hirawat, Samit ;
Juric, Dejan .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1929-1940
[3]   Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome [J].
Arpino, G ;
Bardou, VJ ;
Clark, GM ;
Elledge, RM .
BREAST CANCER RESEARCH, 2004, 6 (03) :R149-R156
[4]   The completeness of the Swedish Cancer Register - a sample survey for year 1998 [J].
Barlow, Lotti ;
Westergren, Kerstin ;
Holmberg, Lars ;
Talback, Mats .
ACTA ONCOLOGICA, 2009, 48 (01) :27-33
[5]   Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer [J].
Baselga, Jose ;
Campone, Mario ;
Piccart, Martine ;
Burris, Howard A., III ;
Rugo, Hope S. ;
Sahmoud, Tarek ;
Noguchi, Shinzaburo ;
Gnant, Michael ;
Pritchard, Kathleen I. ;
Lebrun, Fabienne ;
Beck, J. Thaddeus ;
Ito, Yoshinori ;
Yardley, Denise ;
Deleu, Ines ;
Perez, Alejandra ;
Bachelot, Thomas ;
Vittori, Luc ;
Xu, Zhiying ;
Mukhopadhyay, Pabak ;
Lebwohl, David ;
Hortobagyi, Gabriel N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) :520-529
[6]   Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma [J].
Bomeisl, Philip E. ;
Thompson, Cheryl L. ;
Harris, Lyndsay N. ;
Gilmore, Hannah L. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (12) :1546-1549
[7]   Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma [J].
Chen, Zheling ;
Yang, Jiao ;
Li, Shuting ;
Lv, Meng ;
Shen, Yanwei ;
Wang, Biyuan ;
Li, Pan ;
Yi, Min ;
Zhao, Xiao'ai ;
Zhang, Lingxiao ;
Wang, Le ;
Yang, Jin .
PLOS ONE, 2017, 12 (09)
[8]   Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study [J].
Collins, Laura C. ;
Cole, Kimberly S. ;
Marotti, Jonathan D. ;
Hu, Rong ;
Schnitt, Stuart J. ;
Tamimi, Rulla M. .
MODERN PATHOLOGY, 2011, 24 (07) :924-931
[9]   Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma? [J].
Conlon, Niamh ;
Ross, Dara S. ;
Howard, Jane ;
Catalano, Jeffrey P. ;
Dickler, Maura N. ;
Tan, Lee K. .
BREAST JOURNAL, 2015, 21 (05) :514-519
[10]   Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes [J].
Cristofanilli, M ;
Gonzalez-Angulo, A ;
Sneige, N ;
Kau, SW ;
Broglio, K ;
Theriault, RL ;
Valero, V ;
Buzdar, AU ;
Kuerer, H ;
Buccholz, TA ;
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :41-48